US 7811998
Novobiocin analogues as anticancer agents
granted A61PA61P25/00A61P35/00
Quick answer
US patent 7811998 (Novobiocin analogues as anticancer agents) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/00, A61P35/00